Down-regulation of calcitonin gene transcription by vitamin D requires two widely separated enhancer sequences

Mol Endocrinol. 1993 Aug;7(8):999-1008. doi: 10.1210/mend.7.8.8232320.

Abstract

Transcription of the calcitonin (CT) gene is down-regulated by vitamin D in normal and transformed thyroid C cells. DNA transfer techniques have been previously used to map and characterize a cAMP-induced enhancer at nucleotides -255 to -129 and an enhancer of basal transcription at -1060 to -905 in the CT 5' flanking DNA. The same methods were used to identify a negative response element for vitamin D. Deletion mutants of a genomic fragment of CT extending from nucleotides -1460 to +90 were attached to a promoterless GH gene and transfected individually into the medullary thyroid carcinoma cell line TT. CT nucleotides -1460 to -129 induced significant basal transcription of the GH reporter gene in TT cells. Basal transcription was elevated 3-fold to 4-fold by treatment with cAMP analog. The biologically active metabolite of vitamin D3, 1,25-dihydroxyvitamin D3, had a minor (20%) inhibitory effect on basal transcription but inhibited more than 60% of the cAMP-induced transcription. We further investigated the cAMP-induced response and found that transcriptional activity of the downstream cAMP-induced enhancer was greatly synergized in the presence of the upstream enhancer of basal transcription. The latter enhancer contained three functional CANNTG sequences designated E1 (nucleotides -1060 to -1030), E2 (nucleotides -940 to -920), and E3 (nucleotides -920 to -900). E2 and E3 were essential for maximal cAMP-induced transcription. Detailed mapping of the vitamin D response showed that a minimum requirement for inhibition of the cAMP-induced enhancer by vitamin D was a sequence overlapping E3 (nucleotides -920 to -829). We conclude that a negative response element to vitamin D is located between nucleotides -920 and -829 in the CT 5' flanking DNA. It is possible that vitamin D inhibits transcription by interfering with the synergistic interaction between the cAMP-induced enhancer and the enhancer of basal transcription.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 24,25-Dihydroxyvitamin D 3 / pharmacology
  • Base Sequence
  • Calcitonin / genetics*
  • Calcitriol / pharmacology*
  • Carcinoma, Medullary / pathology
  • Cyclic AMP / antagonists & inhibitors
  • Cyclic AMP / pharmacology
  • Depression, Chemical
  • Enhancer Elements, Genetic*
  • Gene Expression Regulation / drug effects*
  • Humans
  • Molecular Sequence Data
  • Receptors, Calcitriol / metabolism
  • Recombinant Fusion Proteins / biosynthesis
  • Thyroid Neoplasms / pathology
  • Transcription, Genetic
  • Tumor Cells, Cultured

Substances

  • Receptors, Calcitriol
  • Recombinant Fusion Proteins
  • 24,25-Dihydroxyvitamin D 3
  • Calcitonin
  • Cyclic AMP
  • Calcitriol